Patent ductus arteriosus of the preterm infant

SEG Hamrick, G Hansmann - Pediatrics, 2010 - publications.aap.org
A persistently patent ductus arteriosus (PDA) in preterm infants can have significant clinical
consequences, particularly during the recovery period from respiratory distress syndrome …

Management of patent ductus arteriosus in premature infants in 2020

S Parkerson, R Philip, A Talati… - Frontiers in Pediatrics, 2021 - frontiersin.org
The patent ductus arteriosus (PDA) is the most commonly found cardiac condition in
neonates. While there have been several studies and thousands of publications on the topic …

Targeted neonatal echocardiography in the neonatal intensive care unit: practice guidelines and recommendations for training: writing group of the American Society …

L Mertens, I Seri, J Marek, R Arlettaz… - European Journal of …, 2011 - academic.oup.com
LV Left ventricular MPI Myocardial performance index mVCFc Mean velocity of
circumferential fiber shortening NICU Neonatal intensive care unit PA Pulmonary artery PDA …

Patent ductus arteriosus and bronchopulmonary dysplasia–associated pulmonary hypertension: a bayesian meta-analysis

E Villamor, E van Westering-Kroon… - JAMA Network …, 2023 - jamanetwork.com
Importance Bronchopulmonary dysplasia (BPD) is often associated with pulmonary vascular
disease and secondary pulmonary hypertension (PH). The pathogenesis of BPD-associated …

Diagnosis, evaluation, and management of patent ductus arteriosus in preterm neonates

A Jain, PS Shah - JAMA pediatrics, 2015 - jamanetwork.com
Patent ductus arteriosus (PDA) poses a diagnostic and therapeutic dilemma for clinicians.
Diagnosis of persistent PDA and determination of its clinical and hemodynamic significance …

Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure …

BK Gupta, AK Saha, S Mukherjee, B Saha - European journal of pediatrics, 2020 - Springer
Preterm neonates with respiratory distress syndrome (RDS) are commonly treated with
surfactant by intubate surfactant extubate (InSurE) technique. Mode of surfactant …

Managing the patent ductus arteriosus: current treatment options

AM Heuchan, RI Clyman - Archives of Disease in Childhood-Fetal and …, 2014 - fn.bmj.com
Optimal management of the patent ductus arteriosus (PDA) in the premature infant remains
controversial. Despite considerable historical and physiological data indicating that a …

Expert consensus statement 'neonatologist-performed echocardiography (NoPE)'—training and accreditation in UK

Y Singh, S Gupta, AM Groves, A Gandhi… - European journal of …, 2016 - Springer
Targeted echocardiographic assessments of haemodynamic status are increasingly utilised
in many settings. Application in the neonatal intensive care units (NICU) is increasingly …

Nasal HFOV versus nasal IPPV as a post-extubation respiratory support in preterm infants—a randomised controlled trial

S Seth, B Saha, AK Saha, S Mukherjee… - European Journal of …, 2021 - Springer
Early and successful extubation prevents several morbidities in preterm newborns. Several
secondary non-invasive respiratory modalities exist but with their merits and demerits. Given …

Patent ductus arteriosus in preterm infants: do we have the right answers?

H Abdel-Hady, N Nasef, AE Shabaan… - BioMed Research …, 2013 - Wiley Online Library
Patent ductus arteriosus (PDA) is a common clinical condition in preterm infants. Preterm
newborns with PDA are at greater risk for several morbidities, including higher rates of …